Answers are grounded in this paper and cite their sources.
Riboflavin/UVA collagen cross-linking appears to be efficacious in inhibiting the progression of keratoconus by reducing the corneal curvature, spherical equivalent refraction, and refractive cylinder in eyes with progressive keratoconus at average 9-month follow-up.
No takes yet. Share an insight, caveat, or question.
Coşkunseven et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: